chrX-106900843-T-C
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_138382.3(RIPPLY1):āc.362A>Gā(p.Asn121Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00121 in 1,209,909 control chromosomes in the GnomAD database, including 2 homozygotes. There are 481 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_138382.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
RIPPLY1 | NM_138382.3 | c.362A>G | p.Asn121Ser | missense_variant | 4/4 | ENST00000276173.5 | |
RIPPLY1 | NM_001171706.2 | c.221A>G | p.Asn74Ser | missense_variant | 2/2 | ||
CLDN2 | NM_001171092.1 | c.-179+339T>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
RIPPLY1 | ENST00000276173.5 | c.362A>G | p.Asn121Ser | missense_variant | 4/4 | 1 | NM_138382.3 | P1 | |
RIPPLY1 | ENST00000411805.1 | c.221A>G | p.Asn74Ser | missense_variant | 2/2 | 1 | |||
CLDN2 | ENST00000541806.6 | c.-179+339T>C | intron_variant | 1 | P1 | ||||
MORC4 | ENST00000604604.1 | c.112-85057A>G | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.000903 AC: 101AN: 111805Hom.: 1 Cov.: 23 AF XY: 0.000971 AC XY: 33AN XY: 33981
GnomAD3 exomes AF: 0.000811 AC: 147AN: 181245Hom.: 0 AF XY: 0.000877 AC XY: 59AN XY: 67309
GnomAD4 exome AF: 0.00124 AC: 1358AN: 1098052Hom.: 1 Cov.: 30 AF XY: 0.00123 AC XY: 448AN XY: 363482
GnomAD4 genome AF: 0.000903 AC: 101AN: 111857Hom.: 1 Cov.: 23 AF XY: 0.000969 AC XY: 33AN XY: 34043
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 15, 2021 | The c.362A>G (p.N121S) alteration is located in exon 4 (coding exon 4) of the RIPPLY1 gene. This alteration results from a A to G substitution at nucleotide position 362, causing the asparagine (N) at amino acid position 121 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
RIPPLY1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 27, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at